Akari Therapeutics (AKTX)
NASDAQ: AKTX
· Real-Time Price · USD
1.00
0.03 (3.08%)
At close: Aug 15, 2025, 3:58 PM
1.00
0.00%
After-hours: Aug 15, 2025, 04:10 PM EDT
Akari Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 2.58M | 2.6M | 2.25M | 4.18M | 1.31M | 3.85M | 3.85M | 7.18M | n/a | 13.25M | 13.25M | 8.15M | 16.72M | 9.36M | 13.39M | 3.79M | 6.67M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 | -13.25M | n/a | n/a | 0.00 | -0.00 | 0.00 | -0.00 | 0.00 | 0.00 |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 140K | 261K | 92K | 94K | 232K | 197K | 197K | 186.57K | n/a | 100K | 100K | 115.17K | 325.74K | 90.3K | n/a | n/a | n/a |
Total Current Assets | 3.35M | 2.95M | 2.73M | 5.08M | 2.77M | 4.34M | 4.34M | 8M | 13.25M | 13.81M | 13.81M | 11.35M | 19.43M | 11.63M | 14.69M | 4.8M | 7.81M |
Property-Plant & Equipment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Goodwill & Intangibles | 47.61M | 47.61M | n/a | n/a | n/a | 14K | 14K | 15.78K | n/a | 17K | 17K | 18.84K | 21.34K | 22.93K | 23.93K | 25.55K | 26.46K |
Total Long-Term Assets | 47.61M | 47.61M | n/a | n/a | n/a | 14K | 14K | 15.78K | -13.25M | 17K | 17K | 18.84K | 21.34K | 22.93K | 23.93K | 25.55K | 26.46K |
Total Assets | 50.96M | 50.56M | 2.73M | 5.08M | 2.77M | 4.36M | 4.36M | 8.01M | n/a | 13.83M | 13.83M | 11.37M | 19.45M | 11.65M | 14.72M | 4.83M | 7.84M |
Account Payables | 13.07M | 12.41M | 4.78M | 4.69M | 3.21M | 1.67M | 1.67M | 1.03M | n/a | 947K | 947K | 1.63M | 3.08M | 1.79M | 1.92M | 1.69M | 2.83M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 1.85M | 3.26M | 1M | 1M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 3.21M | 1.58M | 3.65M | 1.41M | 1.59M | 1.35M | 1.35M | 1.8M | n/a | 7.95M | 7.95M | n/a | n/a | 1.12M | n/a | n/a | n/a |
Total Current Liabilities | 20.91M | 19.91M | 9.43M | 8.78M | 6.33M | 4.58M | 4.58M | 5.23M | n/a | 12.04M | 12.04M | 3.05M | 5.52M | 6.09M | 3.36M | 3.24M | 3.9M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 266K | 383K | n/a | n/a | n/a | n/a | n/a | n/a | -1.79M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 8.31M | 8.42M | n/a | n/a | n/a | n/a | n/a | n/a | -1.79M | n/a | n/a | 1.63M | 3.08M | 1.79M | n/a | n/a | n/a |
Total Liabilities | 29.21M | 28.33M | 9.43M | 8.78M | 6.33M | 4.58M | 4.58M | 5.23M | -1.79M | 12.04M | 12.04M | 3.05M | 5.52M | 6.09M | 3.36M | 3.24M | 3.9M |
Total Debt | 1.85M | 3.26M | 1M | 1M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock | 5.78M | 5.32M | 2.43M | 2.43M | 1.6M | 1.32M | 1.32M | 1.01M | n/a | 745K | 745K | 593.49K | 593.49K | 475.97K | 475.97K | 396.5K | 384.73K |
Retained Earnings | -250.96M | -247.25M | -243.48M | -240.59M | -233.03M | -227.46M | -227.46M | -220.45M | n/a | -217.45M | -217.45M | -210.56M | -204.88M | -199.71M | -193.92M | -192.47M | -188.12M |
Comprehensive Income | -773K | -738K | -926K | -749K | 51.43M | 51.15M | 51.15M | -825.88K | 1.79M | 51.42M | 51.42M | -621.56K | -573.32K | -540.97K | -447.42K | -420.09K | -341.97K |
Shareholders Equity | 21.75M | 22.23M | -6.69M | -3.7M | -3.55M | -229K | -229K | 2.78M | 1.79M | 1.79M | 1.79M | 8.33M | 13.93M | 5.55M | 11.36M | 1.59M | 3.94M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |